Forest Laboratories (FRX-OLD)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q2 2014 | |||||
| ≡ | Dodge & Cox | Sell 100.00% | 2,615,837 | 0.44 | |
| ≡ | Carl Icahn - Icahn Capital Management | Sell 100.00% | 30,662,005 | 8.59 | |
| Q1 2014 | |||||
| ≡ | Dodge & Cox | Reduce 48.51% | 2,464,476 | 0.41 | |
| ≡ | Bill Nygren - Oakmark Select Fund | Sell 100.00% | 4,200,000 | 6.02 | |
| Q3 2011 | |||||
| ≡ | Richard Pzena - Hancock Classic Value | Sell 100.00% | 1,365,700 | 2.74 | |
| Q1 2010 | |||||
| ≡ | Bruce Berkowitz - Fairholme Capital | Sell 100.00% | 13,299,200 | 5.27 | |
| Q3 2009 | |||||
| ≡ | Bruce Berkowitz - Fairholme Capital | Reduce 16.30% | 2,589,600 | 1.05 | |
| Q2 2009 | |||||
| ≡ | Bruce Berkowitz - Fairholme Capital | Reduce 4.03% | 667,300 | 0.26 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.